Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ESE - ESCO Reports Second Quarter Fiscal 2023 Results


ESE - ESCO Reports Second Quarter Fiscal 2023 Results

St. Louis, May 09, 2023 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the second quarter ended March 31, 2023 (Q2 2023).

Operating Highlight s

  • Q2 2023 GAAP EPS increased 8 percent to $0.69 per share compared to $0.64 per share in Q2 2022.   Q2 2023 Adjusted EPS increased 17 percent to $0.76 per share compared to $0.65 per share in Q2 2022.
  • Q2 2023 Sales increased $24.2 million (11.8 percent) to $229.1 million compared to $204.9 million in Q2 2022.
  • Q2 2023 Entered Orders increased $15.1 million (6 percent) over the prior year period to $251.6 million (book-to-bill of 1.10x), resulting in record ending backlog of $741 million.
  • Net cash used by operating activities was $5 million YTD 2023, as cash flow was negatively impacted by higher working capital requirements, with higher accounts receivable being driven by increased sales and higher inventory related to timing and supply chain issues.
  • Net debt (total borrowings less cash on hand) was $113 million, resulting in a 0.86x leverage ratio and $582 million in liquidity at March 31, 2023.

Bryan Sayler, Chief Executive Officer and President, commented, “Q2 was another solid quarter operationally, as ESCO delivered double-digit revenue growth, expanded operating margins, and achieved 17 percent adjusted earnings per share growth.   It has been an exciting time for me to step into the CEO role. The business has clear momentum and secular growth drivers that should carry us through this year and beyond. We continue to see exciting developments across our aerospace and defense portfolio, with commercial aerospace, military aerospace and Navy customers driving high levels of business activity. We also see growth drivers continue to solidify in the utility and renewable energy markets, which makes us feel good about the long-term prospects for our Utility Solutions Group. Our Test business had a slightly down quarter but serves a variety of strong end markets and offers broad capabilities that give us confidence in its long-term outlook. It is an exciting time to be at ESCO and I look forward to working with leadership across the company as we move our businesses forward.

“Entered orders remained strong in the quarter, with solid growth in commercial aerospace and renewables.   All three segments had book-to-bills above 1.0 and for the second consecutive quarter, we achieved record ending backlog at $741 million.

“Our teams across the company continue to do an excellent job driving growth and delivering solid operating results while navigating challenges related to inflation, supply chain constraints and labor shortages. Even with our strong performance year-to-date, we are still managing some past-due backlog challenges driven by these factors. I’d like to personally thank all of our employees for their dedication, persistence, and tremendous efforts. Their commitment is key to our solid results.”

Segment Performance

A erospace & D efense (A&D)

  • Sales increased $14.2 million (17 percent) to $99.0 million in Q2 2023 from $84.8 million in Q2 2022. Sales growth was driven by commercial aerospace, which increased $8.1 million (27 percent) to $38.2 million in the quarter. In addition, defense aerospace and Navy also delivered solid sales growth.
  • Q2 2023 EBIT increased $4.5 million to $18.8 million from $14.3 million in Q2 2022. Adjusted EBIT increased $5.1 million (35.2 percent) in Q2 2023 to $19.6 million (19.8 percent margin) from $14.5 million (17.1 percent margin) in Q2 2022.
  • Entered Orders increased $17 million (18 percent) to $112 million in Q2 2023 compared to $95 million in Q2 2022.   The orders strength was driven by commercial OEM build rate increases, market share gains at Mayday, a large aftermarket order at PTI, and $7 million in acquired backlog related to CMT. A&D’s book-to-bill of 1.13x in the quarter resulted in record ending backlog of $435 million.

U tility Solutions Group (USG)

  • Sales increased $15.0 million (23 percent) to $79.2 million in Q2 2023 from $64.2 million in Q2 2022. Doble’s sales increased by $10.5 million (19 percent) driven by a strong quarter for condition monitoring products, services, and high voltage test equipment at Phenix.   NRG sales increased $4.5 million (47 percent) on continued strength in the renewables end-market.
  • EBIT increased $2.8 million in Q2 2023 to $14.1 million from $11.3 million in Q2 2022. There were no adjustments to Q2 2023 EBIT of $14.1 million (17.8 percent margin), which also increased $2.8 million from Q2 2022 Adjusted EBIT of $11.3 million (17.7 percent margin). Margins were unfavorably impacted by product mix and increased event costs as trade show activity continued to normalize post-COVID.
  • Entered Orders decreased $2 million (2 percent) to $85 million in Q2 2023. The decrease in orders was primarily driven by an $8 million (11 percent) decrease at Doble related to the timing of a large multi-year DUC contract renewal in the prior year Q2. Order strength continues across the Doble portfolio, highlighted by significant condition monitoring orders. NRG orders increased by $6 million (54 percent) related to continuing strength in both wind and solar, and with significant orders by solar resource monitoring (SRM) customers in the U.S. and Europe. USG’s book-to-bill of 1.07x in the quarter resulted in an ending backlog of $143 million, which is up $26 million compared to prior year.

Test

  • Sales decreased $4.9 million (9 percent) to $51.0 million in Q2 2023 from $55.9 million in Q2 2022, with sales increases in Europe more than offset by declines in the U.S. and Asia. There were disruptions in test and measurement project execution in China related to re-opening of the economy after prior zero-COVID policies.
  • EBIT decreased $1.3 million in Q2 2023 to $7.2 million (14.2 percent margin) from $8.5 million (15.2 percent margin) in Q2 2022 related to lower volume in China. There were no adjustments in either year for the Test segment.
  • Entered Orders decreased $0.1 million to $55.3 million in Q2 2023 compared to $55.4 million in Q2 2022. Despite the slight decrease in orders, it was a solid orders quarter for Test with a book-to-bill of 1.09x, which resulted in an ending backlog of $163 million.

Share Repurchase Program
During Q2 2023, the Company repurchased approximately 81,000 shares for $7.1 million. $8.1 million was paid in the quarter related to the Q2 shares purchased and included $1.0 million related to December purchases that settled in January. Year-to-date, the company has repurchased approximately 138,000 shares for $12.2 million.

Dividend Payment
The next quarterly cash dividend of $0.08 per share will be paid on July 19, 2023 to stockholders of record on July 5, 2023.

Business Outlook – 202 3
The strength of our first half results gives us added confidence in our ability to deliver solid revenue and earnings growth in 2023 and we are again increasing our earnings guidance. We now expect current year adjusted EPS in the range of $3.55 to $3.65 (11 to 14 percent growth). This is based on sales in a range of $930 to $950 million (8 to 11 percent annual growth). Consistent with prior years, revenues and Adjusted EPS are expected to grow sequentially throughout the year. Our expectation is for Q3 Adjusted EPS to be in the range of $0.96 to $1.01 per share (8 to 13 percent growth).

Board of Directors
Effective June 30, 2023, and consistent with the succession plan previously announced, Vic Richey will retire from his roles as a director of the Company, the Executive Chair of the Board, and an employee of the Company. Related to this change, independent director Robert Phillippy has been appointed to serve as Chair of the Board. James Stolze will remain a director but has resigned his position as Lead Director. In addition, given that the role of Board Chair will be held by an independent director, the position of Lead Director has been eliminated by the Board. Patrick Dewar has been appointed to serve as Chair of the Audit and Finance Committee.   All of the foregoing changes are effective June 30, 2023.

C onference Call
The Company will host a conference call today, May 9, at 4:00 p.m. Central Time, to discuss the Company’s Q2 2023 results. A live audio webcast and an accompanying slide presentation will be available on ESCO’s investor website at https://investor.escotechnologies.com . For those unable to participate, a webcast replay will be available after the call on ESCO’s investor website.

F orward-Looking Statements
Statements in this press release regarding Management’s expectations for fiscal 2023, the effects of continuing inflationary pressures, higher interest rates, pressures related to supply chain performance and labor shortages, our guidance for 2023 including revenues, revenue growth, Adjusted EPS, Adjusted EBIT and Adjusted EBITDA margin; the effects of acquisitions, and any other statements which are not strictly historical, are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. securities laws.

Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2022; the availability and acceptance of viable COVID-19 vaccines by enough of the U.S. and world’s population to curtail the pandemic; the continuing impact of the COVID-19 pandemic and the effects of known or unknown COVID-19 variants including labor shortages, facility closures, shelter in place policies or quarantines, material shortages, transportation delays, termination or delays of Company contracts, and the inability of our suppliers or customers to perform; the impacts of natural disasters on the Company’s operations and those of the Company’s customers and suppliers; the timing and content of future contract awards or customer orders; the appropriation, allocation and availability of Government funds; the termination for convenience of Government and other customer contracts or orders; weakening of economic conditions in served markets; the success of the Company’s competitors; changes in customer demands or customer insolvencies; competition; intellectual property rights; technical difficulties; the success of the Company’s acquisition efforts; delivery delays or defaults by customers; performance issues with key customers, suppliers and subcontractors; changes in the costs and availability of certain raw materials; labor disputes; changes in U.S. tax laws and regulations; other changes in laws and regulations including but not limited to changes in accounting standards and foreign taxation; changes in interest rates; costs relating to environmental matters arising from current or former facilities; uncertainty regarding the ultimate resolution of current disputes, claims, litigation or arbitration; and the integration of recently acquired businesses.

Non-GAAP Financial Measures
The financial measures EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS are presented in this press release. The Company defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described in the attached Reconciliation of Non-GAAP Financial Measures, and “Adjusted EPS” as GAAP earnings per share (EPS) excluding the net impact of the items described and reconciled in the attached Reconciliation of Non-GAAP Financial Measures.

EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS are not recognized in accordance with U.S. generally accepted accounting principles (GAAP). However, Management believes EBIT, Adjusted EBIT, EBITDA and Adjusted EBITDA are useful in assessing the operational profitability of the Company’s business segments because they exclude interest, taxes, depreciation and amortization, which are generally accounted for across the entire Company on a consolidated basis. EBIT and EBITDA are also measures used by Management in determining resource allocations within the Company as well as incentive compensation. The presentation of EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS provides important supplemental information to investors by facilitating comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. The use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP.

About ESCO Technologies
ESCO is a global provider of highly engineered products and solutions serving diverse end-markets. It manufactures filtration and fluid control products for the aviation, Navy, space, and process markets worldwide and composite-based products and solutions for Navy, defense, and industrial customers. ESCO is the industry leader in RF shielding and EMC test products; and provides diagnostic instruments, software and services to industrial power users and the electric utility and renewable energy industries. Headquartered in St. Louis, Missouri, ESCO and its subsidiaries have offices and manufacturing facilities worldwide. For more information on ESCO and its subsidiaries, visit the Company’s website at www.escotechnologies.com .

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share amounts)
Three Months
Ended
March 31, 2023
Three Months
Ended
March 31, 2022
Net Sales
$
229,136
204,928
Cost and Expenses:
Cost of sales
142,296
128,375
Selling, general and administrative expenses
53,877
47,959
Amortization of intangible assets
7,030
6,510
Interest expense
2,269
1,020
Other expenses (income), net
314
(604
)
Total costs and expenses
205,786
183,260
Earnings before income taxes
23,350
21,668
Income tax expense
5,472
5,085
Net earnings
$
17,878
16,583
Diluted - GAAP
$
0.69
0.64
Diluted - As Adjusted Basis
$
0.76
(1
)
0.65
(2
)
Diluted average common shares O/S:
25,895
26,045
(1
)
Q2 2023 Adjusted EPS excludes $0.07 per share of after-tax charges consisting of $0.04 of executive management transition costs at Corporate, $0.02 of CMT acquisition inventory step-up charges and $0.01 of restructuring charges within the A&D segment.
(2
)
Q2 2022 Adjusted EPS excludes $0.01 per share of after-tax charges associated with the NEco acquisition inventory step-up charge and Corporate acquisition related costs.


ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share amounts)
Six Months
Ended
March 31, 2023
Six Months
Ended
March 31, 2022
Net Sales
$
434,637
381,938
Cost and Expenses:
Cost of sales
268,679
236,680
Selling, general and administrative expenses
105,179
94,594
Amortization of intangible assets
13,891
12,977
Interest expense
3,927
1,753
Other expenses (income), net
712
(571
)
Total costs and expenses
392,388
345,433
Earnings before income taxes
42,249
36,505
Income tax expense
9,644
8,398
Net earnings
$
32,605
28,107
Diluted - GAAP
$
1.26
1.08
Diluted - As Adjusted Basis
$
1.36
(1
)
1.11
(2
)
Diluted average common shares O/S:
25,919
26,098
(1
)
YTD Q2 2023 Adjusted EPS excludes $0.10 per share of after-tax charges consisting of $0.06 of executive management transition costs at Corporate, $0.02 of CMT acquisition inventory step-up charges and $0.02 of restructuring charges within the A&D segment.
(2
)
YTD Q2 2022 Adjusted EPS excludes $0.03 per share of after-tax charges associated with the Altanova & NEco acquisition inventory step-up charges and Corporate acquisition related costs.


ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Business Segment Information (Unaudited)
(Dollars in thousands)
GAAP
As Adjusted
Q2 2023
Q2 2022
Q2 2023
Q2 2022
Net Sales
Aerospace & Defense
$
98,982
84,821
98,982
84,821
USG
79,161
64,191
79,161
64,191
Test
50,993
55,916
50,993
55,916
Totals
$
229,136
204,928
229,136
204,928
EBIT
Aerospace & Defense
$
18,795
14,349
19,595
14,489
USG
14,061
11,314
14,061
11,331
Test
7,226
8,494
7,226
8,494
Corporate
(14,463
)
(11,469
)
(12,963
)
(11,344
)
Consolidated EBIT
25,619
22,688
27,919
22,970
Less: Interest expense
(2,269
)
(1,020
)
(2,269
)
(1,020
)
Less: Income tax expense
(5,472
)
(5,085
)
(6,001
)
(5,150
)
Net earnings
$
17,878
16,583
19,649
16,800
Note 1: Adjusted net earnings were $19.6 million in Q2 2023 which excludes $0.07 per share of after-tax charges consisting of $0.04 of executive management transition costs at Corporate, $0.02 of CMT acquisition inventory step-up charges and $0.01 of restructuring charges within the A&D segment.
Note 2: Adjusted net earnings were $16.8 million in Q2 2022 which excludes $0.01 per share of after-tax charges associated with the NEco acquisition inventory step-up charge and Corporate acquisition related costs.
EBITDA Reconciliation to Net earnings:
Q2 2023
Q2 2022
Q2 2023
Q2 2022
- As Adjusted
- As Adjusted
Consolidated EBITDA
$
38,162
34,808
40,462
35,090
Less: Depr & Amort
(12,543
)
(12,120
)
(12,543
)
(12,120
)
Consolidated EBIT
25,619
22,688
27,919
22,970
Less: Interest expense
(2,269
)
(1,020
)
(2,269
)
(1,020
)
Less: Income tax expense
(5,472
)
(5,085
)
(6,001
)
(5,150
)
Net earnings
$
17,878
16,583
19,649
16,800


ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Business Segment Information (Unaudited)
(Dollars in thousands)
GAAP
As Adjusted
YTD Q2 2023
YTD Q2 2022
YTD Q2 2023
YTD Q2 2022
Net Sales
Aerospace & Defense
$
181,965
155,065
181,965
155,065
USG
150,206
127,676
150,206
127,676
Test
102,466
99,197
102,466
99,197
Totals
$
434,637
381,938
434,637
381,938
EBIT
Aerospace & Defense
$
31,331
24,304
32,330
24,639
USG
30,192
24,705
30,192
25,172
Test
12,637
12,459
12,637
12,459
Corporate
(27,984
)
(23,210
)
(25,691
)
(22,905
)
Consolidated EBIT
46,176
38,258
49,468
39,365
Less: Interest expense
(3,927
)
(1,753
)
(3,927
)
(1,753
)
Less: Income tax expense
(9,644
)
(8,398
)
(10,401
)
(8,653
)
Net earnings
$
32,605
28,107
35,140
28,959
Note 1: Adjusted net earnings were $35.1 million in YTD 2023 which excludes $0.10 per share of after-tax charges consisting of $0.06 of executive management transition costs at Corporate, $0.02 of CMT acquisition inventory step-up charges and $0.02 of restructuring charges within the A&D segment.
Note 2: Adjusted net earnings were $29.0 million in YTD Q2 2022 which excludes $0.03 per share of after-tax charges associated with the Altanova & NEco acquisition inventory step-up charges and Corporate acquisition related costs.
EBITDA Reconciliation to Net earnings:
YTD Q2 2023
YTD Q2 2022
YTD Q2 2023
YTD Q2 2022
- As Adjusted
- As Adjusted
Consolidated EBITDA
$
71,086
62,550
74,378
63,657
Less: Depr & Amort
(24,910
)
(24,292
)
(24,910
)
(24,292
)
Consolidated EBIT
46,176
38,258
49,468
39,365
Less: Interest expense
(3,927
)
(1,753
)
(3,927
)
(1,753
)
Less: Income tax expense
(9,644
)
(8,398
)
(10,401
)
(8,653
)
Net earnings
$
32,605
28,107
35,140
28,959


ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(Dollars in thousands)
March 31,
2023
September 30,
2022
Assets
Cash and cash equivalents
$
48,221
97,724
Accounts receivable, net
180,817
164,645
Contract assets
128,205
125,154
Inventories
185,753
162,403
Other current assets
27,144
22,696
Total current assets
570,140
572,622
Property, plant and equipment, net
154,020
155,973
Intangible assets, net
401,717
394,464
Goodwill
505,194
492,709
Operating lease assets
41,418
29,150
Other assets
10,113
9,538
$
1,682,602
1,654,456
Liabilities and Shareholders' Equity
Current maturities of long-term debt
$
20,000
20,000
Accounts payable
79,619
78,746
Contract liabilities
119,970
125,009
Other current liabilities
77,466
94,374
Total current liabilities
297,055
318,129
Deferred tax liabilities
81,150
82,023
Non-current operating lease liabilities
37,657
24,853
Other liabilities
44,945
48,294
Long-term debt
141,000
133,000
Shareholders' equity
1,080,795
1,048,157
$
1,682,602
1,654,456


ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows (Unaudited)
(Dollars in thousands)
Six Months
Ended
March 31, 2023
Six Months
Ended
March 31, 2022
Cash flows from operating activities:
Net earnings
$
32,605
28,107
Adjustments to reconcile net earnings to net cash
(used) provided by operating activities:
Depreciation and amortization
24,910
24,292
Stock compensation expense
5,309
3,428
Changes in assets and liabilities
(67,140
)
(41,451
)
Effect of deferred taxes
(1,145
)
8,627
Net cash (used) provided by operating activities
(5,461
)
23,003
Cash flows from investing activities:
Acquisition of business, net of cash acquired
(17,901
)
(15,592
)
Capital expenditures
(10,305
)
(20,715
)
Additions to capitalized software
(5,918
)
(4,727
)
Net cash used by investing activities
(34,124
)
(41,034
)
Cash flows from financing activities:
Proceeds from long-term debt
68,000
88,000
Principal payments on long-term debt and short-term borrowings
(60,000
)
(46,000
)
Dividends paid
(4,128
)
(4,150
)
Purchases of common stock into treasury
(12,217
)
(17,878
)
Other
(2,374
)
(2,719
)
Net cash (used) provided by financing activities
(10,719
)
17,253
Effect of exchange rate changes on cash and cash equivalents
801
(1,130
)
Net decrease in cash and cash equivalents
(49,503
)
(1,908
)
Cash and cash equivalents, beginning of period
97,724
56,232
Cash and cash equivalents, end of period
$
48,221
54,324


ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Other Selected Financial Data (Unaudited)
(Dollars in thousands)
Backlog And Entered Orders - Q2 2023
Aerospace & Defense
USG
Test
Total
Beginning Backlog - 1/1/23
$
422,551
137,286
158,584
718,421
Entered Orders
111,677
84,571
55,328
251,576
Sales
(98,982
)
(79,161
)
(50,993
)
(229,136
)
Ending Backlog - 3/31/23
$
435,246
142,696
162,919
740,861
Backlog And Entered Orders - YTD Q2 2023
Aerospace & Defense
USG
Test
Total
Beginning Backlog - 10/1/22
$
408,269
128,156
158,597
695,022
Entered Orders
208,942
164,746
106,788
480,476
Sales
(181,965
)
(150,206
)
(102,466
)
(434,637
)
Ending Backlog - 3/31/23
$
435,246
142,696
162,919
740,861


ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Reconciliation of Non-GAAP Financial Measures (Unaudited)
EPS – Adjusted Basis Reconciliation – Q2 2023
EPS – GAAP Basis – Q2 2023
$
0.69
Adjustments (defined below)
0.07
EPS – As Adjusted Basis – Q2 2023
$
0.76
Adjustments exclude $0.07 per share consisting of executive management transition costs
at Corporate, CMT acquisition inventory step-up charges and restructuring charges within
the A&D segment in the second quarter of 2023.
The $0.07 of EPS adjustments per share consists of $2.3M of pre-tax charges
offset by $529K of tax benefit for net impact of $1,771K.
EPS – Adjusted Basis Reconciliation – Q2 2022
EPS – GAAP Basis – Q2 2022
$
0.64
Adjustments (defined below)
0.01
EPS – As Adjusted Basis – Q2 2022
$
0.65
Adjustments exclude $0.01 per share consisting of NEco acquisition inventory
step-up charges and Corporate related acquisition costs in the second quarter of 2022.
The $0.01 of EPS adjustments per share consists of $282K of pre-tax charges
offset by $65K of tax benefit for net impact of $217K.
EPS – Adjusted Basis Reconciliation – YTD Q2 2023
EPS – GAAP Basis – YTD Q2 2023
$
1.26
Adjustments (defined below)
0.10
EPS – As Adjusted Basis – YTD Q2 2023
$
1.36
Adjustments exclude $0.10 per share consisting of executive management transition costs
at Corporate, CMT acquisition inventory step-up charges and restructuring charges within
the A&D segment in the first six months of 2023.
The $0.10 of EPS adjustments per share consists of $3,292K of pre-tax charges
offset by $757K of tax benefit for net impact of $2,535K.
EPS – Adjusted Basis Reconciliation – YTD Q2 2022
EPS – GAAP Basis – YTD Q2 2022
$
1.08
Adjustments (defined below)
0.03
EPS – As Adjusted Basis – YTD Q2 2022
$
1.11
Adjustments exclude $0.03 per share consisting of Altanova & NEco acquisition inventory
step-up charges and Corporate related acquisition costs in the first six months of 2022.
The $0.03 of EPS adjustments per share consists of $1,107K of pre-tax charges
offset by $255K of tax benefit for net impact of $852K.



SOURCE ESCO Technologies Inc.
Kate Lowrey, Vice President of Investor Relations, (314) 213-7277


Stock Information

Company Name: ESCO Technologies Inc.
Stock Symbol: ESE
Market: NYSE
Website: escotechnologies.com

Menu

ESE ESE Quote ESE Short ESE News ESE Articles ESE Message Board
Get ESE Alerts

News, Short Squeeze, Breakout and More Instantly...